Research and Development Centered on Manufacturing Technology
First written in FY2016. 28 of 33 entries say "Restated". Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥5,368 million, and the main results were as follows.」
R&D expenses increased from ¥4,136 million in the previous fiscal year to ¥5,368 million, and the scope of activities expanded to search and recommendations, meviy, generative AI, computational geometry, manufacturing technology and other areas. - FY2026-H1RestatedAnnual report
「The total R&D expenses for the current interim consolidated fiscal period were ¥2,641 million.」
The company continued R&D activities in manufacturing technology, service development and other areas, and disclosed R&D expenses of ¥2,641 million for the current interim consolidated fiscal period. - FY2025AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥4,136 million, and the main results were as follows.」
R&D expenses increased from ¥3,983 million in the previous fiscal year to ¥4,136 million. The company conducted service development of ¥2,635 million and product and manufacturing technology development of ¥1,501 million, while advancing expansion of meviy's product areas, support for 2D drawings, and enhancement of its automatic quotation functions. - FY2025-H1RestatedAnnual report
「The total R&D expenses for the current interim consolidated fiscal period were ¥1,725 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥1,725 million for the current interim consolidated fiscal period. - FY2024AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥3,983 million, and the main results were as follows.」
R&D expenses increased from ¥2,801 million in the previous fiscal year to ¥3,983 million. The company conducted service development of ¥2,015 million and product and manufacturing technology development of ¥1,968 million. - FY2024-Q3RestatedAnnual report
「The total R&D expenses for the cumulative period through the third quarter were ¥1,931 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥1,931 million for the cumulative period through the third quarter. - FY2024-Q2RestatedAnnual report
「The total R&D expenses for the cumulative period through the second quarter were ¥1,319 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥1,319 million for the cumulative period through the second quarter. - FY2023AdvancedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥2,801 million, and the main results were as follows.」
R&D expenses increased from ¥1,211 million in the previous fiscal year to ¥2,801 million, with service development and product and manufacturing technology development disclosed as defined areas of activity. - FY2023-Q3RestatedAnnual report
「The total R&D expenses for the cumulative period through the third quarter were ¥1,013 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥1,013 million for the cumulative period through the third quarter. - FY2023-Q2RestatedAnnual report
「The total R&D expenses for the cumulative period through the second quarter were ¥697 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥697 million for the cumulative period through the second quarter. - FY2023-Q1RestatedAnnual report
「The total R&D expenses for the cumulative period through the first quarter were ¥342 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥342 million for the cumulative period through the first quarter. - FY2022RestatedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥1,211 million, and R&D activities are handled by each business division.」
The company continued R&D centered on 駿河生産プラットフォーム, and R&D expenses for the fiscal year were ¥1,211 million. - FY2022-Q3RestatedAnnual report
「The total R&D expenses for the cumulative period through the third quarter were ¥897 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥897 million for the cumulative period through the third quarter. - FY2022-Q2RestatedAnnual report
「The total R&D expenses for the cumulative period through the second quarter were ¥566 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥566 million for the cumulative period through the second quarter. - FY2022-Q1RestatedAnnual report
「The total R&D expenses for the cumulative period through the first quarter were ¥266 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥266 million for the cumulative period through the first quarter. - FY2021RestatedAnnual report
「The Group conducts R&D centered on 駿河生産プラットフォーム, which possesses manufacturing technology. Total R&D expenses for the current consolidated fiscal year were ¥966 million, and R&D activities are handled by each business division.」
The company continued R&D centered on 駿河生産プラットフォーム, and R&D expenses for the fiscal year were ¥966 million. - FY2021-Q3RestatedAnnual report
「The total R&D expenses for the cumulative period through the third quarter were ¥770 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥770 million for the cumulative period through the third quarter. - FY2021-Q2RestatedAnnual report
「The total R&D expenses for the cumulative period through the second quarter were ¥540 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥540 million for the cumulative period through the second quarter. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥300 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥300 million for the cumulative period through the first quarter. - FY2020RestatedAnnual report
「The Group conducts R&D centred on the Suruga Manufacturing Platform, which possesses manufacturing technologies. The Group's total R&D expenses for the fiscal year were ¥1,556 million, and each business division is responsible for R&D activities.」
The Group continues R&D centred on the Suruga Manufacturing Platform, and R&D expenses for the fiscal year were ¥1.556 billion. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥1.224 billion.」
The company continues its R&D activities and disclosed R&D expenses of ¥1.224 billion for the cumulative third quarter. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥823 million.」
The company continues its R&D activities and disclosed R&D expenses of ¥823 million for the cumulative second quarter. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥410 million.」
The company continues its R&D activities and disclosed R&D expenses of ¥410 million for the cumulative first quarter. - FY2019RestatedAnnual report
「The Group conducts R&D centred on the Suruga Manufacturing Platform, which possesses manufacturing technologies. The Group's total R&D expenses for the consolidated fiscal year were ¥1,614 million, and each business division is responsible for R&D activities.」
The Group continues R&D centred on the Suruga Manufacturing Platform, and R&D expenses for the consolidated fiscal year were ¥1.614 billion. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥1.159 billion.」
The company continues its R&D activities and disclosed R&D expenses of ¥1.159 billion for the cumulative third quarter. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥792 million.」
The company continues its R&D activities and disclosed R&D expenses of ¥792 million for the cumulative second quarter. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥414 million.」
The company continues its R&D activities and disclosed R&D expenses of ¥414 million for the cumulative first quarter. - FY2018RestatedAnnual report
「The Group conducts R&D centred on the Suruga Manufacturing Platform, which possesses manufacturing technologies. The Group's total R&D expenses for the consolidated fiscal year were ¥1.845 billion, and each business division is responsible for R&D activities.」
The Group continues R&D centred on the Suruga Manufacturing Platform, and R&D expenses for the consolidated fiscal year were ¥1.845 billion. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥1.395 billion.」
The company continues its R&D activities and disclosed R&D expenses of ¥1.395 billion for the cumulative third quarter. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter were ¥1.019 billion.」
The company continues its R&D activities and disclosed R&D expenses of ¥1.019 billion for the cumulative second quarter. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter were ¥579 million.」
The company continues its R&D activities and disclosed R&D expenses of ¥579 million for the cumulative first quarter. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter were ¥1.226 billion.」
The company continues its R&D activities and disclosed R&D expenses of ¥1.226 billion for the cumulative third quarter. - FY2016First statedAnnual report
「The Group conducts R&D centred on the Suruga Manufacturing Platform, which possesses manufacturing technologies.」
The Group continues R&D centred on the Suruga Manufacturing Platform, advancing product development and productivity improvements in the FA business and higher precision and added value in the mould components business.